Risk For Colorectal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-02-03
Clinical Trial Update: Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma [Phase 2]
Phase 2 trial updating the MUC1 peptide-poly-ICLC adjuvant vaccine in individuals with risk for colorectal cancer (advanced colorectal adeno…